# Time in Glucose Hospital Target

Study · id `cardio:ct-nct05135676` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05135676](<https://clinicaltrials.gov/study/NCT05135676>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05135676

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 166 participants.

## Technical summary

Registry record NCT05135676. Randomized; single masking; primary purpose treatment. Start 2022-05-10 (actual); primary completion 2024-03-01 (actual). Results posted on 2026-09-14.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 166 participants (enrolled count; ClinicalTrials.gov record NCT05135676, source copy `cardio:ctgov-nct05135676-2026-09-14`, retrieved 2026-10-26)
- Started: 2022-05-10 (actual) (ClinicalTrials.gov record NCT05135676, source copy `cardio:ctgov-nct05135676-2026-09-14`, retrieved 2026-10-26)
- Primary completion: 2024-03-01 (actual) (ClinicalTrials.gov record NCT05135676, source copy `cardio:ctgov-nct05135676-2026-09-14`, retrieved 2026-10-26)
- Completion: 2024-03-01 (actual) (ClinicalTrials.gov record NCT05135676, source copy `cardio:ctgov-nct05135676-2026-09-14`, retrieved 2026-10-26)
- Results first posted: 2026-09-14 (ClinicalTrials.gov record NCT05135676, source copy `cardio:ctgov-nct05135676-2026-09-14`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05135676, source copy `cardio:ctgov-nct05135676-2026-09-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05135676-2026-09-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Time in Glucose Hospital Target
- Acronym: TIGHT
- Condition: Diabetes Mellitus, Type 2
- Intervention (Device): Blinded CGM
- Intervention (Device): real-time CGM
- Lead sponsor: Jaeb Center for Health Research
- Lead sponsor class: OTHER
- Collaborator: DexCom, Inc.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Jaeb Center for Health Research (`cardio:org-jaeb-center-for-health-research`)
- Registry lists this organization as a collaborator: DexCom, Inc. (`cardio:org-dexcom-inc`)

## Provenance

Content hash: d3c0d085b2fe35aef223e36a347816c4e8c45f036cb18cdbdbf5b726f3cf45ca
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
